Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Vieillard

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|September 7, 2006
Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infectionVincent Vieillard, Dominique Costagliola, Anne Simon, et al.
Bulletin De L'Academie Nationale De Medecine|September 2, 2009
[Towards a vaccine for HIV infection: role of the gp41 envelope protein]Patrice Debre, Dominique Costagliola, Roger Legrand, et al.
Journal of Innate Immunity|March 18, 2011
Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?Stéphanie Nguyen, Vivien Béziat, Damien Roos-Weil, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2008
A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaquesVincent Vieillard, Roger Le Grand, Jean Dausset, et al.
Cancers|April 30, 2021
Natural Killer Cells in Post-Transplant Lymphoproliferative DisordersCecilia Nakid-Cordero, Marine Baron, Amélie Guihot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2010
Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllersVincent Vieillard, Hugues Fausther-Bovendo, Assia Samri, et al.
Plos One|August 12, 2010
NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRsVivien Béziat, Benjamin Descours, Christophe Parizot, et al.
Critical Reviews in Immunology|February 27, 2019
Immunopathogenesis of the Anti-Synthetase SyndromeCatherine Gayed, Yurdagül Uzunhan, Isabelle Cremer, et al.
Immunogenetics|September 30, 2010
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infectionNadia Wauquier, Cindy Padilla, Pierre Becquart, et al.
Frontiers in Immunology|July 29, 2020
Cell-Mediated Immune Responses to COVID-19 InfectionAmélie Guihot, Elena Litvinova, Brigitte Autran, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|September 7, 2006
Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infectionVincent Vieillard, Dominique Costagliola, Anne Simon, et al.
Bulletin De L'Academie Nationale De Medecine|September 2, 2009
[Towards a vaccine for HIV infection: role of the gp41 envelope protein]Patrice Debre, Dominique Costagliola, Roger Legrand, et al.
Journal of Innate Immunity|March 18, 2011
Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?Stéphanie Nguyen, Vivien Béziat, Damien Roos-Weil, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2008
A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaquesVincent Vieillard, Roger Le Grand, Jean Dausset, et al.
Cancers|April 30, 2021
Natural Killer Cells in Post-Transplant Lymphoproliferative DisordersCecilia Nakid-Cordero, Marine Baron, Amélie Guihot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2010
Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllersVincent Vieillard, Hugues Fausther-Bovendo, Assia Samri, et al.
Plos One|August 12, 2010
NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRsVivien Béziat, Benjamin Descours, Christophe Parizot, et al.
Critical Reviews in Immunology|February 27, 2019
Immunopathogenesis of the Anti-Synthetase SyndromeCatherine Gayed, Yurdagül Uzunhan, Isabelle Cremer, et al.
Immunogenetics|September 30, 2010
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infectionNadia Wauquier, Cindy Padilla, Pierre Becquart, et al.
Frontiers in Immunology|July 29, 2020
Cell-Mediated Immune Responses to COVID-19 InfectionAmélie Guihot, Elena Litvinova, Brigitte Autran, et al.
Pageof 9